Literature DB >> 20375161

Bacteriophage lambda: a paradigm revisited.

Paul C M Fogg1, Heather E Allison, Jon R Saunders, Alan J McCarthy.   

Abstract

Bacteriophage lambda has an archetypal immunity system, which prevents the superinfection of its Escherichia coli lysogens. It is now known that superinfection can occur with toxigenic lambda-like phages at a high frequency, and here we demonstrate that the superinfection of a lambda lysogen can lead to the acquisition of additional lambda genomes, which was confirmed by Southern hybridization and quantitative PCR. As many as eight integration events were observed but at a very low frequency (6.4 x 10(-4)) and always as multiple insertions at the established primary integration site in E. coli. Sequence analysis of the complete immunity region demonstrated that these multiply infected lysogens were not immunity mutants. In conclusion, although lambda superinfection immunity can be confounded, it is a rare event.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375161      PMCID: PMC2903274          DOI: 10.1128/JVI.02177-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Prophage lambda at unusual chromosomal locations. I. Location of the secondary attachment sites and the properties of the lysogens.

Authors:  K Shimada; R A Weisberg; M E Gottesman
Journal:  J Mol Biol       Date:  1972-02-14       Impact factor: 5.469

3.  Mapping of integration and excision crossovers in superinfection double lysogens for phage lambda in Escherichia coli.

Authors:  E Calef
Journal:  Genetics       Date:  1967-03       Impact factor: 4.562

4.  Antitermination and termination functions of the cloned nutL, N, and tL1 modules of coliphage lambda.

Authors:  D Drahos; W Szybalski
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

5.  A theory of modular evolution for bacteriophages.

Authors:  D Botstein
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

6.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

7.  The formation of homoimmune double lysogens of phage lambda and the segregation of single lysogens from them.

Authors:  D Freifelder; I Kirschner
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

8.  Inactivation of bacteriophage lambda by combined X-ray and U.V.-light exposure.

Authors:  K D Martignoni; I Haselbacher
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1979-05

9.  The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2.

Authors:  R Serra-Moreno; J Jofre; M Muniesa
Journal:  J Bacteriol       Date:  2008-05-09       Impact factor: 3.490

10.  Immunity profiles of wild-type and recombinant shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens.

Authors:  Heather E Allison; Martin J Sergeant; Chloë E James; Jon R Saunders; Darren L Smith; Richard J Sharp; Trevor S Marks; Alan J McCarthy
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more
  16 in total

Review 1.  Bacteriophage secondary infection.

Authors:  Stephen T Abedon
Journal:  Virol Sin       Date:  2015-01-13       Impact factor: 4.327

2.  Viruses and the origin of microbiome selection and immunity.

Authors:  Steven D Quistad; Juris A Grasis; Jeremy J Barr; Forest L Rohwer
Journal:  ISME J       Date:  2016-12-16       Impact factor: 10.302

Review 3.  Mutualistic interplay between bacteriophages and bacteria in the human gut.

Authors:  Andrey N Shkoporov; Christopher J Turkington; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2022-06-30       Impact factor: 60.633

Review 4.  Co-infection and super-infection models in evolutionary epidemiology.

Authors:  Samuel Alizon
Journal:  Interface Focus       Date:  2013-12-06       Impact factor: 3.906

Review 5.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

6.  Insights into the genome architecture and evolution of Shiga toxin encoding bacteriophages of Escherichia coli.

Authors:  Graça Pinto; Marta Sampaio; Oscar Dias; Carina Almeida; Joana Azeredo; Hugo Oliveira
Journal:  BMC Genomics       Date:  2021-05-19       Impact factor: 3.969

7.  Characterization of the relationship between integrase, excisionase and antirepressor activities associated with a superinfecting Shiga toxin encoding bacteriophage.

Authors:  P C M Fogg; D J Rigden; J R Saunders; A J McCarthy; H E Allison
Journal:  Nucleic Acids Res       Date:  2010-11-09       Impact factor: 16.971

8.  Comparative genomics of Shiga toxin encoding bacteriophages.

Authors:  Darren L Smith; David J Rooks; Paul C M Fogg; Alistair C Darby; Nick R Thomson; Alan J McCarthy; Heather E Allison
Journal:  BMC Genomics       Date:  2012-07-16       Impact factor: 3.969

9.  Genes from the exo-xis region of λ and Shiga toxin-converting bacteriophages influence lysogenization and prophage induction.

Authors:  Sylwia Bloch; Bożena Nejman-Faleńczyk; Joanna M Łoś; Sylwia Barańska; Krzysztof Łepek; Agnieszka Felczykowska; Marcin Łoś; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Arch Microbiol       Date:  2013-08-27       Impact factor: 2.552

10.  Novel Moraxella catarrhalis prophages display hyperconserved non-structural genes despite their genomic diversity.

Authors:  Amir Ariff; Michael J Wise; Charlene M Kahler; Chin Yen Tay; Fanny Peters; Timothy T Perkins; Barbara J Chang
Journal:  BMC Genomics       Date:  2015-10-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.